Us Bancorp \De\ Argenx Se Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Argenx Se stock. As of the latest transaction made, Us Bancorp \De\ holds 4,350 shares of ARGX stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,350

Previous 4,034 7.83%

Holding current value

$2.45 Million

Previous $1.73 Million 36.04%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$434.22 - $551.9 $137,213 - $174,400	316 Added 7.83%	4,350 $2.36 Million
Q2 2024 Aug 06, 2024	BUY	$356.01 - $451.55 $89,714 - $113,790	252 Added 6.66%	4,034 $1.73 Million
Q1 2024 May 07, 2024	BUY	$356.95 - $413.29 $182,401 - $211,191	511 Added 15.62%	3,782 $1.49 Million
Q4 2023 Feb 09, 2024	BUY	$338.91 - $506.01 $115,229 - $172,043	340 Added 11.6%	3,271 $1.24 Million
Q3 2023 Nov 03, 2023	BUY	$369.35 - $548.43 $482,740 - $716,798	1,307 Added 80.48%	2,931 $1.44 Million
Q2 2023 Aug 09, 2023	SELL	$360.14 - $422.58 $103,360 - $121,280	-287 Reduced 15.02%	1,624 $632,000
Q1 2023 May 09, 2023	BUY	$334.23 - $403.65 $77,875 - $94,050	233 Added 13.89%	1,911 $712,000
Q4 2022 Feb 13, 2023	SELL	$342.17 - $402.31 $255,600 - $300,525	-747 Reduced 30.8%	1,678 $635,000
Q3 2022 Oct 27, 2022	BUY	$343.2 - $395.75 $41,527 - $47,885	121 Added 5.25%	2,425 $856,000
Q2 2022 Aug 01, 2022	BUY	$269.58 - $378.88 $136,407 - $191,713	506 Added 28.14%	2,304 $874,000
Q1 2022 May 11, 2022	BUY	$254.45 - $351.06 $137,657 - $189,923	541 Added 43.04%	1,798 $566,000
Q4 2021 Feb 11, 2022	SELL	$272.01 - $353.03 $44,337 - $57,543	-163 Reduced 11.48%	1,257 $441,000
Q3 2021 Nov 10, 2021	BUY	$295.0 - $350.58 $74,930 - $89,047	254 Added 21.78%	1,420 $428,000
Q2 2021 Aug 05, 2021	BUY	$257.11 - $319.92 $10,541 - $13,116	41 Added 3.64%	1,166 $351,000
Q1 2021 Apr 28, 2021	BUY	$268.3 - $380.31 $29,244 - $41,453	109 Added 10.73%	1,125 $309,000
Q4 2020 Feb 04, 2021	BUY	$248.13 - $308.36 $107,688 - $133,828	434 Added 74.57%	1,016 $299,000
Q3 2020 Nov 10, 2020	BUY	$215.51 - $272.51 $20,473 - $25,888	95 Added 19.51%	582 $153,000
Q2 2020 Aug 07, 2020	BUY	$127.44 - $232.72 $1,146 - $2,094	9 Added 1.88%	487 $109,000
Q1 2020 May 13, 2020	BUY	$108.83 - $165.23 $6,856 - $10,409	63 Added 15.18%	478 $63,000
Q4 2019 Feb 04, 2020	BUY	$106.59 - $164.21 $44,234 - $68,147	415 New	415 $67,000
Q3 2019 Nov 08, 2019	SELL	$113.31 - $150.51 $1,473 - $1,956	-13 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$115.0 - $141.58 $23,690 - $29,165	-206 Reduced 94.06%	13 $2,000
Q1 2019 May 08, 2019	BUY	$98.85 - $134.59 $790 - $1,076	8 Added 3.79%	219 $27,000
Q4 2018 Feb 13, 2019	SELL	$63.81 - $109.82 $20,610 - $35,471	-323 Reduced 60.49%	211 $20,000
Q3 2018 Nov 01, 2018	SELL	$75.5 - $96.63 $10,419 - $13,334	-138 Reduced 20.54%	534 $40,000
Q2 2018 Aug 08, 2018	SELL	$74.84 - $100.16 $506,217 - $677,482	-6,764 Reduced 90.96%	672 $56,000
Q1 2018 May 08, 2018	BUY	$56.95 - $85.19 $423,480 - $633,472	7,436 New	7,436 $598,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account